Standout Papers

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of c... 2021 2026 2022 2024202
  1. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial (2021)
    Martin Kankam, Michael Lund et al. The Lancet

Immediate Impact

5 from Science/Nature 107 standout
Sub-graph 1 of 18

Citing Papers

Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
Tirzepatide for Obesity Treatment and Diabetes Prevention
2024 Standout
24 intermediate papers

Works of Michael Lund being referenced

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
2021 Standout
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
2020

Author Peers

Author Last Decade Papers Cites
Michael Lund 344 137 298 222 27 665
Martin Bæk Blond 392 89 294 200 30 726
Charlotte Janus 309 171 388 240 20 744
H. L. Lickley 328 203 237 47 30 661
Jorge Calles 294 129 129 71 21 720
F. W. Kemmer 316 144 326 47 26 697
Sven Carlström 208 72 296 77 31 634
Ali Asmar 229 250 413 99 28 737
Christian R. Juhl 246 105 302 238 26 699
Jason J. Winnick 264 263 316 36 25 768
K. I. Birkeland 181 74 365 54 16 794

All Works

Loading papers...

Rankless by CCL
2026